| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.8 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | 0.0099 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |